{
 "PrintNo":"A1022","Session":2023,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2023-01-13T10:09:49.947019Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2024-01-03","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2023-01-13","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2024-01-03","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":610,"Name":"Edward Braunstein","Short":"BRAUNSTEIN"},{"ID":906,"Name":"Rebecca Seawright","Short":"SEAWRIGHT"}],
 "Title":"Relates to labeling prescription bottles of opioids",
 "Summary":"Requires prescription bottles containing opioids to have a label affixed concerning the addictive nature of the drug.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3333, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to labeling prescription bottles of opioids",
 "PreviousVersions":["A10356-2015","A7460-2017","A2872-2019","A345-2021"]
}